Literature DB >> 16086236

Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells.

Xianyang Yio1, Jie-yu Zhang, Mark Babyatsky, Anli Chen, Jing Lin, Qui-Xiang Fan, J Lawrence Werther, Steven Itzkowitz.   

Abstract

BACKGROUND AND AIM: Trefoil factor family 3 (TFF3) is expressed by intestinal epithelial cells and it mainly functions to protect the mucosa from injury. Expression of TFF3 has been correlated with a poor prognosis in patients with cancer, but little is known about whether TFF3 directly contributes to the malignant behavior of cancer cells. The present study was conducted to determine whether TFF3 expression contributes to the malignant behavior of cancer cells in vitro and in vivo.
METHODS: Two subclones of a metastatic rat colorectal cancer cell line, demonstrated previously to manifest aggressive (LN cells) and non-aggressive (LP cells) growth in vivo, were analyzed for expression of TFF3 and tested in assays of cancer cell migration, invasion, and apoptosis in vitro, and mortality in vivo.
RESULTS: The aggressive LN cell line endogenously expressed TFF3 and supported the transcription of a TFF3 promoter-driven reporter construct, whereas the non-aggressive LP cell line did not express TFF3. LN cells demonstrated enhanced migration, invasion, and less apoptosis compared to LP cells. Transfecting TFF3 into LP cells enhanced their ability to migrate, invade, block apoptosis, and behave more aggressively in vivo, thereby resembling the phenotype of LN cells.
CONCLUSIONS: In rat colon cancer cells, both endogenous and constitutive expression of TFF3 correlates with an aggressive phenotype. These data provide direct evidence that TFF3 contributes to the malignant behavior of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086236     DOI: 10.1007/s10585-005-6615-z

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  39 in total

1.  Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE.

Authors:  Ji-Yeon Lee; Eun-Mi Eom; Dae-Sik Kim; Young Mie Ha-Lee; Dong-Hee Lee
Journal:  Genomics       Date:  2003-07       Impact factor: 5.736

2.  Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo.

Authors:  H Uchino; H Kataoka; H Itoh; R Hamasuna; M Koono
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

3.  Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma.

Authors:  Takasuke Yamachika; J Lawrence Werther; Carol Bodian; Mark Babyatsky; Masae Tatematsu; Yoshitaka Yamamura; Anli Chen; Steven Itzkowitz
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

4.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

Authors:  Y Hippo; M Yashiro; M Ishii; H Taniguchi; S Tsutsumi; K Hirakawa; T Kodama; H Aburatani
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

5.  Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.

Authors:  M C Rio; J P Bellocq; J Y Daniel; C Tomasetto; R Lathe; M P Chenard; A Batzenschlager; P Chambon
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

6.  Somatic mutations of the trefoil factor family 1 gene in gastric cancer.

Authors:  W S Park; R R Oh; J Y Park; J H Lee; M S Shin; H S Kim; H K Lee; Y S Kim; S Y Kim; S H Lee; N J Yoo; J Y Lee
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

7.  The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS.

Authors:  D P Calnan; B R Westley; F E May; D N Floyd; T Marchbank; R J Playford
Journal:  J Pathol       Date:  1999-07       Impact factor: 7.996

8.  Differential expression of human spasmolytic polypeptide (trefoil factor family-2) in pancreatic carcinomas, ampullary carcinomas, and mucin-producing tumors of the pancreas.

Authors:  G Ohshio; H Suwa; Y Kawaguchi; M Imamura; Y Yamaoka; H Yamabe; M Matsumoto; H Yoshioka; Y Hashimoto; H Takeda
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

9.  Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

Authors:  H Mashimo; D C Wu; D K Podolsky; M C Fishman
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

10.  A rat model to study the role of STn antigen in colon cancer.

Authors:  S Ogata; I Ho; J Maklansky; A Chen; J L Werther; M Reddish; B M Longenecker; E Sigurdson; S Iishi; J Y Zhang; S H Itzkowitz
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

View more
  15 in total

1.  Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.

Authors:  Ming-Liang You; Yi-Jun Chen; Qing-Yun Chong; Ming-Ming Wu; Vijay Pandey; Ru-Mei Chen; Liang Liu; Lan Ma; Zheng-Sheng Wu; Tao Zhu; Peter E Lobie
Journal:  Oncotarget       Date:  2017-06-13

2.  Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.

Authors:  Nagarajan Kannan; Jian Kang; Xiangjun Kong; Jianzhong Tang; Jo K Perry; Kumarasamypet M Mohankumar; Lance D Miller; Edison T Liu; Hichem C Mertani; Tao Zhu; Prudence M Grandison; Dong-Xu Liu; Peter E Lobie
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

3.  Increased immunoexpression of trefoil factors in salivary gland tumors.

Authors:  Ponlatham Chaiyarit; Poramaporn Klanrit; Pensri Photipakdee; Ajiravudh Subarnbhesaj; Andrew S Giraud
Journal:  Clin Oral Investig       Date:  2014-05       Impact factor: 3.573

4.  Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.

Authors:  Akram Yusup; Bailikezi Huji; Cheng Fang; Fei Wang; Tuerxunjiang Dadihan; Hai-Jiang Wang; Halmurat Upur
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

5.  Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.

Authors:  Brody Winn; Rosemarie Tavares; Jacqueline Fanion; Lelia Noble; John Gao; Edmond Sabo; Murray B Resnick
Journal:  Hum Pathol       Date:  2008-11-07       Impact factor: 3.466

6.  Trefoil factor-3 expression in human colon cancer liver metastasis.

Authors:  Mark Babyatsky; Jing Lin; Xianyang Yio; Anli Chen; Jie-yu Zhang; Yan Zheng; Christina Twyman; Xiuliang Bao; Myron Schwartz; Swan Thung; J Lawrence Werther; Steven Itzkowitz
Journal:  Clin Exp Metastasis       Date:  2008-11-02       Impact factor: 5.150

7.  Physiological stress induces the metastasis marker AGR2 in breast cancer cells.

Authors:  Daniel R Zweitzig; Denis A Smirnov; Mark C Connelly; Leon W M M Terstappen; S Mark O'Hara; Elizabeth Moran
Journal:  Mol Cell Biochem       Date:  2007-08-11       Impact factor: 3.396

8.  Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.

Authors:  Yiqing Qu; Yie Yang; Dedong Ma; Wei Xiao
Journal:  Oncol Rep       Date:  2012-01-11       Impact factor: 3.906

9.  CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression.

Authors:  Hong-Yong Cui; Shi-Jie Wang; Fei Song; Xu Cheng; Gang Nan; Yu Zhao; Mei-Rui Qian; Xi Chen; Jia-Yue Li; Fen-Ling Liu; Yu-Meng Zhu; Ruo-Fei Tian; Bin Wang; Bin Wu; Yang Zhang; Xiu-Xuan Sun; Ting Guo; Xiang-Min Yang; Hai Zhang; Ling Li; Jing Xu; Hui-Jie Bian; Jian-Li Jiang; Zhi-Nan Chen
Journal:  Signal Transduct Target Ther       Date:  2021-07-14

10.  Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.

Authors:  Soyoung Im; Changyoung Yoo; Ji-Han Jung; Hyun Joo Choi; Jinyoung Yoo; Chang Suk Kang
Journal:  Int J Med Sci       Date:  2012-12-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.